Slow Capital, Inc. Crispr Therapeutics Ag Transaction History

Slow Capital, Inc.

$693 Million
Q4 2024

A detailed history of Slow Capital, Inc. transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Slow Capital, Inc. holds 61,575 shares of CRSP stock, worth $2.56 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares

61,575

Previous 85,910 28.33%

Holding current value

$2.56 Million

Previous $4.04 Million 39.97%

% of portfolio

0.35%

Previous 0.63%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 22, 2025	SELL	$38.65 - $55.15 $940,547 - $1.34 Million	-24,335 Reduced 28.33%	61,575 $2.42 Million
Q3 2024 Oct 18, 2024	BUY	$44.62 - $62.75 $298,686 - $420,048	6,694 Added 8.45%	85,910 $4.04 Million
Q2 2024 Jul 24, 2024	BUY	$51.17 - $68.18 $595,976 - $794,092	11,647 Added 17.24%	79,216 $4.28 Million
Q1 2024 Apr 17, 2024	BUY	$60.67 - $89.12 $56,605 - $83,148	933 Added 1.4%	67,569 $4.61 Million
Q4 2023 Jan 30, 2024	BUY	$38.62 - $72.18 $15,756 - $29,449	408 Added 0.62%	66,636 $4.17 Million
Q3 2023 Oct 19, 2023	BUY	$45.39 - $59.0 $109,162 - $141,895	2,405 Added 3.77%	66,228 $3.01 Million
Q2 2023 Aug 09, 2023	SELL	$43.47 - $67.77 $125,150 - $195,109	-2,879 Reduced 4.32%	63,823 $3.58 Million
Q1 2023 Apr 26, 2023	BUY	$41.0 - $56.12 $91,225 - $124,867	2,225 Added 3.45%	66,702 $3.02 Million
Q4 2022 Feb 13, 2023	BUY	$39.19 - $65.67 $795,361 - $1.33 Million	20,295 Added 45.93%	64,477 $2.62 Million
Q3 2022 Oct 27, 2022	SELL	$61.1 - $83.78 $63,299 - $86,796	-1,036 Reduced 2.29%	44,182 $2.89 Million
Q2 2022 Jul 28, 2022	BUY	$43.23 - $73.83 $124,761 - $213,073	2,886 Added 6.82%	45,218 $2.75 Million
Q1 2022 May 02, 2022	BUY	$53.19 - $79.24 $640,141 - $953,653	12,035 Added 39.72%	42,332 $2.66 Million
Q4 2021 Feb 08, 2022	BUY	$70.09 - $111.29 $815,076 - $1.29 Million	11,629 Added 62.29%	30,297 $2.3 Million
Q3 2021 Oct 21, 2021	BUY	$110.2 - $156.64 $5,950 - $8,458	54 Added 0.29%	18,668 $2.09 Million
Q2 2021 Jul 29, 2021	BUY	$100.84 - $161.89 $224,570 - $360,529	2,227 Added 13.59%	18,614 $3.01 Million
Q1 2021 May 20, 2021	BUY	$110.72 - $210.04 $432,472 - $820,416	3,906 Added 31.3%	16,387 $2.37 Million
Q1 2021 May 05, 2021	SELL	$110.72 - $210.04 $422,839 - $802,142	-3,819 Reduced 23.43%	12,481 $1.52 Million
Q4 2020 Feb 11, 2021	BUY	$79.67 - $173.23 $22,307 - $48,504	280 Added 1.75%	16,300 $2.5 Million
Q3 2020 Nov 04, 2020	BUY	$78.5 - $100.64 $233,694 - $299,605	2,977 Added 22.82%	16,020 $1.34 Million
Q2 2020 Aug 10, 2020	BUY	$38.5 - $76.05 $5,005 - $9,886	130 Added 1.01%	13,043 $959,000
Q1 2020 May 12, 2020	SELL	$33.68 - $62.53 $121,618 - $225,795	-3,611 Reduced 21.85%	12,913 $548,000
Q4 2019 Feb 14, 2020	BUY	$36.68 - $73.13 $126,986 - $253,176	3,462 Added 26.5%	16,524 $1.01 Million
Q3 2019 Nov 07, 2019	SELL	$40.99 - $52.56 $7,173 - $9,198	-175 Reduced 1.32%	13,062 $535,000
Q2 2019 Aug 01, 2019	SELL	$35.45 - $48.2 $8,791 - $11,953	-248 Reduced 1.84%	13,237 $623,000
Q1 2019 May 16, 2019	BUY	$28.02 - $40.87 $377,849 - $551,131	13,485 New	13,485 $482,000

Others Institutions Holding CRSP

# of Institutions

485

Shares Held

57.9M

Call Options Held

1.09M

Put Options Held

1.9M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.24B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Slow Capital, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Slow Capital, Inc. with notifications on news.

Account